Yale Urology Ranks Among Top 50 Programs in Nation
Yale Urology has ranked among the top 50 urology programs in the nation and #1 in Connecticut in U.S. News & World Report’s just-released listing. Yale Urology and Yale New Haven Hospital were 47th in the United States among nearly 5,000 hospitals/programs tracked and surveyed in the annual ranking.
Yale Urology also scored "excellent" and "high performing" [the highest scores available] in nurse staffing numbers, advanced technologies, patient services, and prostate cancer surgery/treatments.
Yale School of Medicine’s urology chair and professor, Isaac Y. Kim, MD, PhD, MBA, says he is extremely proud of the department’s consistent hard work and commitment. “I see this as just another sign we’re on the right road to becoming a destination urology program.” Kim also serves as chief of urology at Yale New Haven Hospital.
You may view Yale Urology’s complete U.S. News & World Report "scorecard", as well as Yale New Haven Health's news release.
Personalized therapeutic approaches in ccRCC remain challenging
April 15th 2024"As a kidney cancer community, we need to investigate these molecular subtypes prospectively in clinical trials to determine whether specific subtypes benefit from certain therapies or not," says David A. Braun, MD, PhD.
CAR T-cell therapy explored as potential option for advanced renal cell carcinoma
November 13th 2023Researchers are exploring the potential of CAR T-cell therapy in patients with renal cell carcinoma who have disease progression following treatment with checkpoint inhibitors and VEGF inhibitors.
Study shows promise of immunotherapy treatment for penile cancer
August 14th 2023“These findings provide encouraging evidence that immune checkpoint inhibitors can be effective in treating a subset of patients with penile squamous cell carcinoma," said co-first author Amin Nassar, a clinical fellow at Yale School of Medicine.
